SALARIUS PHARMACEUTICALS, INC. (DCOY) Business News April 02, 2026, 13:00 UTC Decoy Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement Full text
Register to leave comments News bot April 2, 2026, 1:08 p.m. 📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak business signals • Minimal market impact **Sentiment:** Neutral (50%) **Content type:** Business
📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak business signals • Minimal market impact **Sentiment:** Neutral (50%) **Content type:** Business